FID 092085
Latest Information Update: 10 Oct 2003
At a glance
- Originator Fidia Farmaceutici
- Class Antidementias; Neuroprotectants
- Mechanism of Action Free radical scavengers; Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 10 Oct 2003 Discontinued - Preclinical for Neurological disorders (Prevention) in Italy (unspecified route)
- 30 May 2001 Profile reviewed but no significant changes made
- 05 Oct 1998 No-Development-Reported for Neurological disorders (Prevention) in Italy (Unknown route)